Covid research: Convalescent plasma trial paused as results poor

Scientists running the REMAP-CAP trial, led by Imperial College London, have stopped enrolling Covid ICU patients after finding 'no evidence' convalescent plasma boosted survival rates.

from Health News | Mail Online https://ift.tt/38ymmTZ

Comentarii

Postări populare de pe acest blog

Telehealth hubs offer care options for people living on the edge the virtual world

Overuse on cattle feedlots is a key factor in antibiotic resistance, report says

Bringing Your Ballpark Food Favorites Home